TNF and neoplasm: Furthermore, CY in combination with etanercept, a therapeutic TNF antagonist, markedly inhibited the growth of established CT26 tumor in mice, by eliminating TNFR2-expressing Treg activity through blockade of TNF–TNFR2 interaction (75).